Laboratorios Silanes S.A. de C.V.   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Mexico City Mexico (1943)
Status: No NME R&D (1943)

Organization Overview

First Clinical Trial
2007
NCT00941239
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Laboratorios Silanes | Laboratorios Silanes S.A. de C.V.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Hyperlipidemias (Phase 3)

Insulin Resistance (Phase 2)

Metabolic Syndrome (Phase 2)

Obesity (Phase 3)

Overweight (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 31
  • # of Trial APIs: 22